Aurobindo arm Eugia U.S. recalling antibacterial drug

Eugia U.S. LLC is voluntarily recalling a lot of Vancomycin Hydrochloride injection due to the discovery of glass particles inside the vials. The company is coordinating with distributors to replace the affected medical supplies.
Why it matters
Drug recalls are critical for patient safety and highlight the regulatory oversight required in the pharmaceutical supply chain.
HYDERABAD Aurobindo Pharma subsidiary Eugia US LLC is voluntarily recalling a lot of Vancomycin Hydrochloride for Injection USP 1.25g/Vial-30mL (single dose vial) due to presence of particulate matter identified as a glass particle inside the vial. Eugia had shipped the entire lot to wholesalers in the U.S. from September 2-15. It notified the distributors and customers by recall letters and is arranging for return/replacement of all recalled products, the U.S.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in